Capital International LTD Crispr Therapeutics Ag Transaction History

Capital International LTD

  • $2.23 Billion
  • Q3 2024

A detailed history of Capital International LTD transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Capital International LTD holds 125,604 shares of CRSP stock, worth $6.01 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
125,604
Previous 126,131 0.42%
Holding current value
$6.01 Million
Previous $6.81 Million 13.36%
% of portfolio
0.26%
Previous 0.33%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$44.62 - $62.75 $23,514 - $33,069
-527 Reduced 0.42%
125,604 $5.9 Million
Q2 2024

Aug 13, 2024
SELL
$51.17 - $68.18 $32,697 - $43,567
-639 Reduced 0.5%
126,131 $6.81 Million
Q1 2024

May 14, 2024
BUY
$60.67 - $89.12 $1.94 Million - $2.84 Million
31,908 Added 33.64%
126,770 $8.64 Million
Q4 2023

Feb 13, 2024
SELL
$38.62 - $72.18 $4,170 - $7,795
-108 Reduced 0.11%
94,862 $5.94 Million
Q3 2023

Nov 13, 2023
SELL
$45.39 - $59.0 $8,260 - $10,738
-182 Reduced 0.19%
94,970 $4.31 Million
Q2 2023

Aug 11, 2023
BUY
$43.47 - $67.77 $113,804 - $177,421
2,618 Added 2.83%
95,152 $5.34 Million
Q1 2023

May 15, 2023
BUY
$41.0 - $56.12 $583,594 - $798,812
14,234 Added 18.18%
92,534 $4.19 Million
Q4 2022

Feb 14, 2023
BUY
$39.19 - $65.67 $86,805 - $145,459
2,215 Added 2.91%
78,300 $3.18 Million
Q3 2022

Nov 14, 2022
BUY
$61.1 - $83.78 $1.71 Million - $2.34 Million
27,936 Added 58.02%
76,085 $4.97 Million
Q2 2022

Aug 15, 2022
BUY
$43.23 - $73.83 $212,345 - $362,652
4,912 Added 11.36%
48,149 $2.93 Million
Q4 2021

Feb 14, 2022
BUY
$70.09 - $111.29 $198,915 - $315,841
2,838 Added 7.02%
43,237 $3.28 Million
Q3 2021

Nov 15, 2021
BUY
$110.2 - $156.64 $49,810 - $70,801
452 Added 1.13%
40,399 $4.52 Million
Q2 2021

Aug 16, 2021
SELL
$100.84 - $161.89 $448,838 - $720,572
-4,451 Reduced 10.03%
39,947 $6.47 Million
Q1 2021

May 14, 2021
SELL
$110.72 - $210.04 $2.76 Million - $5.24 Million
-24,951 Reduced 35.98%
44,398 $5.41 Million
Q4 2020

Feb 16, 2021
BUY
$79.67 - $173.23 $72,977 - $158,678
916 Added 1.34%
69,349 $10.6 Million
Q3 2020

Nov 13, 2020
BUY
$78.5 - $100.64 $5.37 Million - $6.89 Million
68,433 New
68,433 $5.72 Million

Others Institutions Holding CRSP

# of Institutions
491
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.74B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Capital International LTD Portfolio

Follow Capital International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email